Trials / Terminated
TerminatedNCT00681668
Quetiapine in Postpartum Depression
The Effect of the Atypical Antipsychotic Quetiapine in the Treatment of Postpartum Depressive Disorder With Psychotic Symptoms
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- Female
- Age
- 18 Years – 39 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the efficacy and tolerability of quetiapine in female patients with postpartum depressive disorder with psychotic symptoms
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Quetiapine | 150-800 mg, oral, twice a day (bid) |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2008-05-21
- Last updated
- 2010-12-21
- Results posted
- 2010-09-17
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00681668. Inclusion in this directory is not an endorsement.